Elucidating a biological role for chromium at a molecular level

Accounts of Chemical Research

Volumn 33, Issue 7, 2000, Pages 503-510

  Vincent, John B ^a  

^a UNIVERSITY OF ALABAMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; CARRIER PROTEIN; CHROMIUM; CHROMIUM PICOLINATE; CHROMODULIN; LIPID; OLIGOPEPTIDE; PICOLINIC ACID; PICOLINIC ACID DERIVATIVE; TRACE ELEMENT;

ARTICLE; CARBOHYDRATE METABOLISM; CARDIOVASCULAR DISEASE; CHEMISTRY; DIABETES MELLITUS; DIET SUPPLEMENTATION; GLUCOSE TOLERANCE; HUMAN; INSULIN SENSITIVITY; LIPID METABOLISM; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; SIGNAL TRANSDUCTION;

CARBOHYDRATE METABOLISM; CARDIOVASCULAR DISEASES; CARRIER PROTEINS; CHROMIUM; DIABETES MELLITUS; HUMANS; LIPID METABOLISM; PICOLINIC ACIDS;

EID: 0033928634     PISSN: 00014842     EISSN: None     Source Type: Journal    
DOI: 10.1021/ar990073r     Document Type: Article

References (64)

1. Schwarz K.; Mertz, W. Chromium(III) and glucose tolerance factor. Arch. Biochem. Biophys. 1959, 85, 292-295.
2. Mertz, W.; Schwarz, K. Relation of glucose tolerance factor to impaired intravenous glucose tolerance of rats on stock diets. J. Physiol. 1959, 196, 614-618.
3. Striffler, J. S.; Polansky, M. M.; Anderson, R. A. Overproduction of insulin in the chromium-deficient rat. Metabolism 1999, 48, 1063-1068.
4. Striffler, J. S.; Polansky, M. M. Dietary chromium decreases insulin resistance in rats fed a high-fat, mineral imbalanced diet. Metabolism 1998, 47, 396-400.
5. Anderson, R. A. Chromium and parenteral nutrition. Nutrition 1995, 11, 83-86.
6. Holm, R. H.; Kennepohl, P.; Solomon, E. I. Structural and functional aspects of metal sites in biology. Chem. Rev. 1996, 96, 2239-2314.
7. Davis, C. M.; Vincent, J. B. Chromium in carbohydrate and lipid metabolism. J. Biol. Inorg. Chem. 1997, 2, 675-679.
8. Vincent, J. B. Mechanisms of chromium action: low-molecular-weight chromium-binding substance. J. Am. Coll. Nutr. 1999, 18, 6-12.
9. Mertz, W.; Roginski, E. E.; Schwarz, K. Effect of trivalent chromium complexes on glucose uptake by epididymal fat tissue of rats. J. Biol. Chem. 1961, 236, 318-322.
10. Mertz, W.; Roginski, E. E. The effect of trivalent chromium on galactose entry in rat epididymal fat tissue. J. Biol. Chem. 1963, 238, 868-872,
11. Mertz, W.; Roginski, E. E.; Schroeder, H. A. Some aspects of chromium-deficient rats raised in a strictly controlled environment. J. Nutr. 1965, 86, 107-112.
12. Toepfer, E. W.; Mertz, W.; Polansky, M. M.; Roginski, E. E.; Wolf, W. R. Preparation of chromium-containing material of glucose tolerance factor activity from Brewer's yeast extracts and by synthesis. J. Agric. Food Chem. 1977, 25, 162-166.
13. Sumrall, K. H.; Vincent, J. B. Is glucose tolerance factor an artifact produced by acid hydrolysis of low-molecular-weight chromium-binding substance? Polyhedron 1997, 16, 4171-4177.
14. Anderson, R. A.; Brantner, J. H.; Polansky, M. M. An improved assay for biologically active chromium. J. Agric. Food Chem. 1978, 26, 1219-1221.
15. Vincent, J. B. Relationship between glucose tolerance factor and low-molecular-weight chromium-binding substance. J. Nutr. 1994, 124, 117-118.
16. Christian, G. D.; Knoblock, E. C.; Purdy, W. C.; Mertz, W. A polarographic study of chromium-insulin-mitochondrial interaction. Biochim. Biophys. Acta 1963, 66, 420-423.
17. Gonzalez-Vergara, E.; Hegenauer, J.; Saltman, P.; Sabat, M.; Ibers, J. A. Synthesis and structure of a trinuclear chromium(III)-nicotinic acid complex, Inorg. Chim. Acta 1982, 66, 115-118.
18. Gerdom, L. E.; Goff, H. M. Ligation modes for nicotinic acid binding to the chromium(III) salen complex, Inorg. Chem. 1982, 27, 3847-3848.
19. Chang, J. C.; Gerdom, L. E.; Baenziger, N. C.; Goff, H. M. Synthesis and molecular structure of carboxyl-bound nicotinic acid (niacin) complexes of chromium(III). Inorg. Chem. 1983, 22, 1739-1744.
20. Cooper, J. A.; Anderson, B. F.; Buckley, P. D.; Blackwell, L. F. Structure and biological activity of nitrogen and oxygen coordinated nicotinic acid complexes of chromium, Inorg. Chim. Acta 1984, 91, 1-9.
21. 2-carboxy-latopyridine-O,O)-triaquatrichromium(III) perchlorates. Inorg. Chim. Acta 1988, 141, 41-47.
22. Stearns, D. M.; Armstrong, W. H. Mononuclear and binuclear chromium(III) picolinate complexes, Inorg. Chem. 1992, 31, 5178-5184.
23. Evans, G. W.; Pouchnik, D. J. Composition and biological activity of chromium-pyridine carboxylate complexes. J. Inorg. Biochem. 1993, 49, 177-187.
24. Evans, G. W.; Bowman, T. D. Chromium picolinate increases membrane fluidity and rate of insulin internalization. J. Inorg. Biochem. 1992, 46, 243-250.
25. Stearns, D. M.; Wise, J. P., Sr.; Patierno, S. R.; Wetterhahn, K. E. Chromium(III) picolinate produces chromosome damage in Chinese hamster ovary cells. FASEB J. 1995, 9, 1643-1648.
26. Speetjens, J. K.; Collins, R. A.; Vincent, J. B.; Woski, S. A. The nutritional supplement chromium(III) tris(picolinate) cleaves DNA. Chem. Res. Toxicol. 1999, 12, 483-487.
27. Sugden, K. D.; Geer, R. D.; Rogers, S. J. Oxygen radical-mediated DNA damage by redox-active Cr(III) complexes. Biochemistry 1992, 37, 11626-11631.
28. 2O. Polyhedron 1999, 18, 2891-2897.
29. Gammelgaard, B.; Jensen, K.; Steffansen, B. In vitro metabolism and permeation studies in rat jejunum. J. Trace Elements Med. Biol. 1999, 13, 82-88.
30. 3 to LMWCr. J. Biol. Inorg. Chem. 2000, 5, 129-136.
31. Hasten, D. L.; Hegsted, M.; Keenan, M. J.; Morris, G. S. Effects of various forms of dietary chromium on growth and body composition in the rat. Nutr. Res. 1997, 17, 283-294.
32. Hasten, D. L.; Hegsted, M.; Keenan, M. J.; Morris, G. S. Dosage effects of chromium picolinate on growth and body composition in the rat. Nutr. Res. 1997, 17, 1175-1186.
33. Anderson, R. A.; Bryden, N. A.; Polansky, M. M. Lack of toxicity of chromium chloride and chromium picolinate in rats. J. Am. Coll. Nutr. 1997, 6, 273-279.
34. Glass, M. M.; Belmore, K.; Vincent, J. B. Nuclear magnetic resonance studies of multinuclear chromium assemblies. Polyhedron 1993, 12, 133-140.
35. 2O, py). Spectrochim. Acta 1994, 50A, 2365-2370.
36. Vincent, J. B. Heteronuclear carboxylates of chromium(III) and iron(III). Inorg. Chem. 1994, 33, 5604-5606.
37. Kingry, K. F.; Royer, A. C.; Vincent, J. B. Nuclear magnetic resonance studies of chromium(III) pyridinecarboxylate complexes. J. Inorg. Biochem. 1998, 72, 79-88.
38. Yamamoto, A.; Wada, O.; Suzuki, H. Purification and properties of biologically active chromium complex from bovine colostrum. J. Nutr. 1988, 118, 39-45.
39. Yamamoto, A.; Wada, O.; Manabe, S. Evidence that chromium is an essential factor for biological activity of low-molecular-weight chromium-binding substance. Biochem. Biophys. Res. Commun. 1989, 163, 189-193.
40. Yamamoto, A.; Wada, O.; Ono, T. Isolation of a biologically active low-molecular-mass chromium compound from rabbit liver. Eur. J. Biochem. 1987, 165, 627-631.
41. Davis, C. M.; Vincent, J. B. Isolation and characterization of a biologically active form of chromium oligopeptide from bovine liver. Arch. Biochem. Biophys. 1997, 339, 335-343.
42. Yamamoto, A.; Wada, O.; Ono, T. Distribution and chromium-binding capacity of a low-molecular-weight, chromium-binding substance in mice. J. Inorg. Biochem. 1984, 22, 91-102.
43. Davis, C. M.; Vincent, J. B. Chromium oligopeptide activates insulin receptor tyrosine kinase activity. Biochemistry 1997, 36, 4382-4385.
44. Davis, C. M.; Sumrall, K. H.; Vincent, J. B. The biologically active form of chromium may activate a membrane phosphotyrosine phosphatase (PTP). Biochemistry 1996, 35, 12963-12969.
45. Wada, O.; Wu, G. Y.; Yamamoto, A.; Manabe, S.; Ono, T. Purification and chromium-excretory function of low-molecular-weight, chromium-binding substances from dog liver. Environ. Res. 1983, 32, 228-239.
46. Yoshimoto, S.; Sakamoto, K.; Wakabayashi, I.; Masui, H. Effect of chromium administration on glucose tolerance in stroke-prone spontaneously hypertensive rats with streptozotocin-induced diabetes. Metabolism 1992, 41, 636-642.
47. Davis, C. M.; Royer, A. C.; Vincent, J. B. Synthetic multinuclear chromium assembly activates insulin receptor kinase activity: functional model for low-molecular-weight chromium-binding substance. Inorg. Chem. 1997, 36, 5316-5320.
48. Morris, B. W.; MacNeil, S.; Stanley, K.; Gray, T. A.; Fraser, R. The inter-relationship between insulin and chromium in hyperinsulinaemic euglycaemic clamps in healthy volunteers. J. Endocrinol. 1993, 139, 339-345.
49. Morris, B. W.; Gray, T. A.; MacNeil, S. Glucose-dependent uptake of chromium in human and rat insulin-sensitive tissues. Clin. Chem. 1993, 84, 477-482.
50. Anderson, R. A.; Polansky, M. M.; Bryden, N. A.; Roginski, E. E.; Patterson, K. Y.; Veillon, C.; Glinsmann, W. Urinary chromium excretion of human subjects: effects of chromium supplementation and glucose loading. Am. J. Clin. Nutr. 1982, 36, 1184-1193.
51. Anderson, R. A.; Polansky, M. M.; Bryden, N. A.; Roginski, E. E.; Patterson, K. Y.; Reamer, D. C. Effect of exercise (running) on serum glucose, insulin, glucagon, and chromium secretion. Diabetes 1982, 31, 212-216.
52. Kozlovsky, A. S.; Moser, P. B.; Reisner, S.; Anderson, R. A. Effects of diets high in simple sugars on urinary chromium losses. Metabolism 1986, 35, 515-518.
53. Anderson, R. A., Bryden, N. A.; Polansky, M. M.; Reiser, S. Urinary chromium excretion and insulogenic properties of carbohydrates. Am. J. Clin. Nutr. 1990, 57, 864-868.
54. Wu, G. Y.; Wada, O. Studies on a specific chromium binding substance (a low molecular weight binding substance) in urine. Jpn. J. Ind. Health. 1981, 23, 505-512.
55. Anderson, R. A. Essentiality of chromium in humans. Sci. Total Environ. 1989, 88, 75-81.
56. + decreases plasma cholesterol and triglycerides in rats. J. Biol. Inorg. Chem. 1999, 4, 838-845.
57. Meador, W. E.; Means, A. R.; Quiocho, F. A. Target enzyme recognition by calmodulin. Science 1992, 257, 1251-1255.
58. Cannon, R. D.; White, R. P. Chemical and physical properties of triangular bridged metal complexes. Prog. Inorg. Chem. 1988, 36, 195-297.
59. Nagi, M.; Harton, A.; Donald, S.; Lee, Y.-S.; Sabat, M.; O'Connor, C. J.; Vincent, J. B. An unsymmetric trinuclear chromium(III) oxo carboxylate. Inorg. Chem. 1995, 34, 3813-3820.
60. Harton, A.; Terrell, K.; Huffman, J. C.; MacDonald, C.; Beatty, A.; Li, S.; O'Connor, C.; Vincent, J. B. Synthesis and characterization of novel oxo-bridged dinuclear and hydroxo-bridged trinuclear chromium(III) assemblies. Inorg. Chem. 1997, 36, 4875-4882.
61. 2] Core. Inorg Chem. 1991, 30, 856-858.
62. Donald, S.; Terrell, K.; Robinson, K.; Vincent, J. B. Modelling chromium biochemistry. Polyhedron 1995, 14, 971-976.
63. Ellis, T.; Glass. M.; Harton, A.; Folting, K.; Huffman, J. C.; Vincent, J. B. Synthetic models for low-molecular-weight chromium-binding substance. Inorg. Chem. 1994, 33, 5522-5527.
64. + do not cleave DNA under physiologically-relevant conditions. Polyhedron 1999, 18, 2617-2624.